Glad to see Boston getting the recognition it deserves as biotech’s equivalent of Silicon Valley. The best is yet ahead for the region, for our biotech industry, and for its impacts on human health and sustainability. bostonglobe.com/2021/06/15/bus… The Boston Globe Scott Kirsner

Our co-founders Noubar Afeyan and Avak Kahvejian have written a new piece on the power of #bioplatforms. Read their essay to learn more about what defines bioplatforms and why they matter on a global scale. bit.ly/3zwWCCN

A big congratulations to our founder, Flagship Pioneering!

Missed our CEO Pearl Huang at the Endpoints News R&D summit? No problem—view the panel on demand to hear her perspective alongside insights from leaders at AstraZeneca, Johnson & Johnson, Pfizer Inc., and Sanofi. bio21.endpts.com #BIO21 #Biotechnology #BIODigital

Interested in the bioplatform approach to life science innovation? Flagship Pioneering's Geoffrey von Maltzahn shares thoughts on the benefits, different types, and future of platforms. bit.ly/3qxbQDN #Bioplatforms #Biotechnology #FlagshipPioneering

Check out the June issue of PharmaVoice to learn about trends and challenges facing chief medical officers today, including thoughts from Cygnal Therapeutics CMO John Wagner. bit.ly/3v3gxFY

Timothy Zheng, Ph.D., has joined Cygnal Therapeutics as SVP of Biology. Tim brings two decades of extensive experience in drug discovery and development to the team. Welcome to Cygnal, Tim! bit.ly/2VtdtXr

Cygnal’s Scientific Advisory Board is a group of extraordinary scientists and researchers. We're pleased to share that Jennifer Petter, Ph.D., cofounder/CSO of Arrakis Therapeutics, has joined our SAB. Learn more about Jennifer on our website. bit.ly/3elPro0

Later this month, our CEO Pearl Huang will speak on a panel about mentorship, leadership, and other challenges in #biotech R&D. Sign up to attend and hear her thoughts! bit.ly/3rluqz3

John Hohneker, M.D., an experienced leader in biotech and pharma, has joined Cygnal Therapeutics's Board of Directors. John most recently served as the CEO of Anokion between January 2018 and January 2021. Welcome, John! cygnaltx.com

Want to join an interdisciplinary team of 50+ inquiring scientists? We're hiring for several open roles. Take a look at our website and apply! bit.ly/3leAZm4

Our team recently volunteered with the Charles River Watershed Association (Charles River Watershed Association) to clean up invasive water chestnuts from the river. We had a great time having fun and helping our community!

Job alert: We're looking for a Principal Scientist of Protein Chemistry & Protein Analysis. If you're interested in joining a collaborative team, apply online today! bit.ly/3jUWdmu

Next month, @Cygnaltx CEO Pearl Huang will speak at the Longwood Healthcare Leaders meeting about advancing platform technologies alongside leaders from @Synlogic_Tx, @Rubius_tx, Takeda, and Tectonic Therapeutic. Register to attend and hear their insights. bit.ly/3zkMyLS

On October 7, our CEO Pearl Huang will speak at the Boston Business Journal's Women Who Lead in Life Sciences event. Come hear her insights on leadership, the role of a CEO, and more! bit.ly/3uea5gF #BBJLIFESCIENCES

A big congratulations to Michelle Monje🎗️ 🟦 on receiving a MacArthur Foundation genius grant! Michelle conducts ground-breaking research into #CancerNeuroscience. It's a privilege to have her on our SAB. bit.ly/3oi8nK1

Congratulations to Drs. Julius and Patapoutian! This is a new frontier of science, and we use these laureates' fundamental discoveries daily in Cygnal's labs. It's exciting to see this recognition for their research into the important roles neurons play in the human body.

ICYMI: Cygnal Therapeutics CEO Pearl Huang spoke at a recent Boston Business Journal event about women and life science careers. Read Rowan Walrath’s feature for insights from 7 local leaders, including Pearl. bit.ly/3EpFXTj #BBJLIFESCIENCES

Scientist position at a cool Cambridge company, Cygnal Therapeutics. Nerve-tissue interactions, in endometriosis! Get industry pay while having the fun of a postdoc position, working with both the amazing Cygnal folks, and my lab. boards.greenhouse.io/cygnaltherapeu…

We're looking for enthusiastic and entrepreneurially-minded immunologists and neuroscientists to join our dynamic team. Help us advance the promise of exoneural biology—check out our open roles and apply today! bit.ly/3leAZm4 #TeamCygnal #ExoneuralBiology